[9] Important safety considerations include monitoring for signs of acute pancreatitis (severe, persistent abdominal pain, sometimes with vomiting) which requires urgent medical assessment, and potential worsening of diabetic retinopathy, particularly in patients with pre-existing retinopathy experiencing rapid improvement in blood glucose control
It is also the single most effective tool for catching errors before they become problems
How often do you need to take Semaglutide GLP-1 injections for effective results
Plus, youll have 24/7 access to your care team, educational resources, and so much more
Semaglutide, proprietary name OZEMPIC, developed by Novo Nordisk and first approved by USFDA on 05 December 2017 as a GLP-1 receptor agonist and indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus